Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease.

Cavedo E, Dubois B, Colliot O, Lista S, Croisile B, Tisserand GL, Touchon J, Bonafe A, Ousset PJ, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Galluzzi S, Delmaire C, Ceccaldi M, Girard N, Lehericy S, Duveau F, Chupin M, Sarazin M, Dormont D, Hampel H; Hippocampus Study Group..

J Clin Psychiatry. 2016 Oct 25. doi: 10.4088/JCP.15m10413. [Epub ahead of print]

PMID:
27780331
2.

From face processing to face recognition: Comparing three different processing levels.

Besson G, Barragan-Jason G, Thorpe SJ, Fabre-Thorpe M, Puma S, Ceccaldi M, Barbeau EJ.

Cognition. 2017 Jan;158:33-43. doi: 10.1016/j.cognition.2016.10.004.

PMID:
27776224
3.

Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France.

Hommet C, Novella JL, Auriacombe S, Vercelletto M, Berrut G, Belliard S, Desmidt T, Ceccaldi M.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Sep 1;14(3):274-86. doi: 10.1684/pnv.2016.0629.

PMID:
27651009
4.

Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations.

Eusebio A, Koric L, Félician O, Guedj E, Ceccaldi M, Azulay JP.

Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):488-502. doi: 10.1016/j.neurol.2016.07.009.

PMID:
27561438
5.

Seizures in dominantly inherited Alzheimer disease.

Zarea A, Charbonnier C, Rovelet-Lecrux A, Nicolas G, Rousseau S, Borden A, Pariente J, Le Ber I, Pasquier F, Formaglio M, Martinaud O, Rollin-Sillaire A, Sarazin M, Croisile B, Boutoleau-Bretonnière C, Ceccaldi M, Gabelle A, Chamard L, Blanc F, Sellal F, Paquet C, Campion D, Hannequin D, Wallon D; PHRC GMAJ Collaborators..

Neurology. 2016 Aug 30;87(9):912-9. doi: 10.1212/WNL.0000000000003048.

PMID:
27466472
6.

ABCA7 rare variants and Alzheimer disease risk.

Le Guennec K, Nicolas G, Quenez O, Charbonnier C, Wallon D, Bellenguez C, Grenier-Boley B, Rousseau S, Richard AC, Rovelet-Lecrux A, Bacq D, Garnier JG, Olaso R, Boland A, Meyer V, Deleuze JF, Amouyel P, Munter HM, Bourque G, Lathrop M, Frebourg T, Redon R, Letenneur L, Dartigues JF, Pasquier F, Rollin-Sillaire A, Génin E, Lambert JC, Hannequin D, Campion D; CNR-MAJ collaborators..

Neurology. 2016 Jun 7;86(23):2134-7. doi: 10.1212/WNL.0000000000002627.

PMID:
27037229
7.

Erratum to: Route and survey processing of topographical memory during navigation.

Latini-Corazzini L, Nesa MP, Ceccaldi M, Guedj E, Thinus-Blanc C, Cauda F, D'Agata F, Péruch P.

Psychol Res. 2016 Jul;80(4):727. No abstract available.

PMID:
26892772
8.

Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease.

Teipel SJ, Cavedo E, Grothe MJ, Lista S, Galluzzi S, Colliot O, Chupin M, Bakardjian H, Dormont D, Dubois B, Hampel H; Hippocampus Study Group..

Neuropharmacology. 2016 Sep;108:128-35. doi: 10.1016/j.neuropharm.2016.02.005.

PMID:
26876309
9.

Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment.

Joubert S, Gour N, Guedj E, Didic M, Guériot C, Koric L, Ranjeva JP, Felician O, Guye M, Ceccaldi M.

Cortex. 2016 Jan;74:217-32. doi: 10.1016/j.cortex.2015.10.014.

PMID:
26694580
10.

SORL1 rare variants: a major risk factor for familial early-onset Alzheimer's disease.

Nicolas G, Charbonnier C, Wallon D, Quenez O, Bellenguez C, Grenier-Boley B, Rousseau S, Richard AC, Rovelet-Lecrux A, Le Guennec K, Bacq D, Garnier JG, Olaso R, Boland A, Meyer V, Deleuze JF, Amouyel P, Munter HM, Bourque G, Lathrop M, Frebourg T, Redon R, Letenneur L, Dartigues JF, Génin E, Lambert JC, Hannequin D, Campion D; CNR-MAJ collaborators..

Mol Psychiatry. 2016 Jun;21(6):831-6. doi: 10.1038/mp.2015.121.

PMID:
26303663
11.

Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons.

Nicolas G, Wallon D, Charbonnier C, Quenez O, Rousseau S, Richard AC, Rovelet-Lecrux A, Coutant S, Le Guennec K, Bacq D, Garnier JG, Olaso R, Boland A, Meyer V, Deleuze JF, Munter HM, Bourque G, Auld D, Montpetit A, Lathrop M, Guyant-Maréchal L, Martinaud O, Pariente J, Rollin-Sillaire A, Pasquier F, Le Ber I, Sarazin M, Croisile B, Boutoleau-Bretonnière C, Thomas-Antérion C, Paquet C, Sauvée M, Moreaud O, Gabelle A, Sellal F, Ceccaldi M, Chamard L, Blanc F, Frebourg T, Campion D, Hannequin D.

Eur J Hum Genet. 2016 May;24(5):710-6. doi: 10.1038/ejhg.2015.173.

PMID:
26242991
12.

De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease.

Rovelet-Lecrux A, Charbonnier C, Wallon D, Nicolas G, Seaman MN, Pottier C, Breusegem SY, Mathur PP, Jenardhanan P, Le Guennec K, Mukadam AS, Quenez O, Coutant S, Rousseau S, Richard AC, Boland A, Deleuze JF, Frebourg T, Hannequin D, Campion D; CNR-MAJ collaborators..

Mol Psychiatry. 2015 Sep;20(9):1046-56. doi: 10.1038/mp.2015.100.

PMID:
26194182
13.

Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks.

Didic M, Felician O, Gour N, Bernard R, Pécheux C, Mundler O, Ceccaldi M, Guedj E.

Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1512-21. doi: 10.1007/s00259-015-3057-y.

PMID:
25900275
14.

Fast, but not slow, familiarity is preserved in patients with amnestic mild cognitive impairment.

Besson G, Ceccaldi M, Tramoni E, Felician O, Didic M, Barbeau EJ.

Cortex. 2015 Apr;65:36-49. doi: 10.1016/j.cortex.2014.10.020.

PMID:
25618326
15.

Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease.

Dubois B, Chupin M, Hampel H, Lista S, Cavedo E, Croisile B, Louis Tisserand G, Touchon J, Bonafe A, Ousset PJ, Ait Ameur A, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Delmaire C, Ceccaldi M, Girard N, Dufouil C, Lehericy S, Tonelli I, Duveau F, Colliot O, Garnero L, Sarazin M, Dormont D; “Hippocampus Study Group”.; Hippocampus Study Group..

Alzheimers Dement. 2015 Sep;11(9):1041-9. doi: 10.1016/j.jalz.2014.10.003.

PMID:
25596420
16.

A phase II trial of tideglusib in Alzheimer's disease.

Lovestone S, Boada M, Dubois B, Hüll M, Rinne JO, Huppertz HJ, Calero M, Andrés MV, Gómez-Carrillo B, León T, del Ser T; ARGO investigators..

J Alzheimers Dis. 2015;45(1):75-88. doi: 10.3233/JAD-141959.

PMID:
25537011
17.

The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.

Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonça A, Didic M, Eriksdotter M, Félician O, Frölich L, Gertz HJ, Hallikainen M, Hasselbalch SG, Hausner L, Heuser I, Jessen F, Jones RW, Kurz A, Lawlor B, Lleo A, Martinez-Lage P, Mecocci P, Mehrabian S, Monsch A, Nobili F, Nordberg A, Rikkert MO, Orgogozo JM, Pasquier F, Peters O, Salmon E, Sánchez-Castellano C, Santana I, Sarazin M, Traykov L, Tsolaki M, Visser PJ, Wallin ÅK, Wilcock G, Wilkinson D, Wolf H, Yener G, Zekry D, Frisoni GB.

Alzheimers Dement. 2015 Feb;11(2):195-206.e1. doi: 10.1016/j.jalz.2014.06.006.

PMID:
25150733
18.

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.

Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M; Subjective Cognitive Decline Initiative (SCD-I) Working Group..

Alzheimers Dement. 2014 Nov;10(6):844-52. doi: 10.1016/j.jalz.2014.01.001. Review.

19.

Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty.

Robert PH, König A, Amieva H, Andrieu S, Bremond F, Bullock R, Ceccaldi M, Dubois B, Gauthier S, Kenigsberg PA, Nave S, Orgogozo JM, Piano J, Benoit M, Touchon J, Vellas B, Yesavage J, Manera V.

Front Aging Neurosci. 2014 Mar 24;6:54. doi: 10.3389/fnagi.2014.00054.

20.

Clinical, neuropsychological, and metabolic characteristics of transient epileptic amnesia syndrome.

Mosbah A, Tramoni E, Guedj E, Aubert S, Daquin G, Ceccaldi M, Félician O, Bartolomei F.

Epilepsia. 2014 May;55(5):699-706. doi: 10.1111/epi.12565.

Items per page

Supplemental Content

Loading ...
Support Center